Zaleplon
- Generic Name
- Zaleplon
- Brand Names
- Sonata
- Drug Type
- Small Molecule
- Chemical Formula
- C17H15N5O
- CAS Number
- 151319-34-5
- Unique Ingredient Identifier
- S62U433RMH
Overview
Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States.
Background
Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States.
Indication
For the treatment of short-term treatment of insomnia in adults.
Associated Conditions
- Insomnia
Clinical Trials
FDA Approved Products
zaleplon
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:5 mg in 1 1
Approved: 2022/01/21
NDC:71335-0236
Zaleplon
Manufacturer:Hikma Pharmaceuticals USA Inc.
Route:ORAL
Strength:5 mg in 1 1
Approved: 2019/03/12
NDC:0054-0084
zaleplon
Manufacturer:Preferred Pharmaceuticals Inc.
Route:ORAL
Strength:10 mg in 1 1
Approved: 2023/10/24
NDC:68788-7208
zaleplon
Manufacturer:A-S Medication Solutions
Route:ORAL
Strength:10 mg in 1 1
Approved: 2021/06/28
NDC:50090-1564
ZALEPLON
Manufacturer:Aurobindo Pharma Limited
Route:ORAL
Strength:10 mg in 1 1
Approved: 2021/12/08
NDC:65862-215
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath